Presenter: Dr. Munir Ghesani, MD, FACNM, FACR, FSNMMI
Medical Director of the United Theranostics, Princeton and Chief Medical Officer of the United Theranostics

Date: Wednesday, August 28, 2024
Time: 3:30pm – 4:30pm EDT

Munir Ghesani, MD, FACNM, FACR, FSNMMI is the Medical Director of the United Theranostics, Princeton and Chief Medical Officer of the United Theranostics. Previously, he has served as the Systems Chief of Nuclear Medicine and Molecular Imaging at the Mount Sinai Health, New York. Dr. Ghesani has been actively involved in clinical practice, research, clinical trials and education for more than 25 years, primarily focusing on nuclear medicine, molecular imaging and targeted radiopharmaceutical therapies.

Dr. Ghesani has more than 200 publications in peer-reviewed journals and is the Editor-in-Chief of a three-part book on nuclear medicine and molecular imaging. He has given more than 150 presentations at regional, national, and international conferences. Dr. Ghesani has served in leadership roles in various societies and colleges, including the Immediate Past President of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Past-President of the Education and Research Foundation of Nuclear Medicine and Molecular Imaging, Past Chairman of the American Board of Nuclear Medicine, Past Chairman of the Government Relations Committee and the FDA Task Force of the SNMMI and Past Chairman of the Nuclear Medicine and PET Accreditation Committee of the American College of Radiology. In January 2020, he was awarded the ACNM Personal Best Mentor of the Year. He has been awarded as the Fellow of the American College of Nuclear Medicine (2006), the American College of Radiology (2018) and the Society of Nuclear Medicine and Molecular Imaging (2023).

In this session, Dr. Ghesani will help you to:

• understand high sensitivity of PET portion of PET/CT, providing excellent negative predictive value.
• understand how high negative predictive value in turn improves clinical outcomes.
• recognize that all attempts should be made to improve the specificity to decrease the number of false-positives.

Approved for 1.0 CE credit from SNMMI.